Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06098404 · ClinicalTrials.gov registry record

Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

A clinical trial of Cancer, sponsored by The University of Texas Medical Branch, Galveston.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT06098404 is a study of Cancer that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 250 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06098404, a study of Cancer, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.

Conditions Studied

Study Locations (1)

Texas

  • The University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-03-04
Est. Completion 2026-10

What the Registry Record Tells You About NCT06098404

The ClinicalTrials.gov registry entry for NCT06098404 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT06098404 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06098404 about?

NCT06098404 is a clinical study titled "Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study". The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.

What is the current status of trial NCT06098404?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2024-03-04. Estimated completion is 2026-10.

What conditions does trial NCT06098404 study?

This clinical trial studies the following conditions: Cancer.

Who is sponsoring clinical trial NCT06098404?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06098404 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.